Podcast with Dr. Ronan Kelly: First report of comprehensive biomarker analyses from CheckMate 577 evaluating adjuvant nivolumab vs. placebo in resected oesophageal or gastroesophageal junction cancer
Ariez Publishing
Podcast with Dr. Ronan Kelly: First report of comprehensive biomarker analyses from CheckMate 577 evaluating adjuvant nivolumab vs. placebo in resected oesophageal or gastroesophageal junction cancer
00:00 / 09:53